BIOS : Analysis & Opinions

  1. Strong Sell on BioScrip - Analyst Blog

    July 9, 2013
    BioScrip lowered to Zacks Rank #5 (Strong Sell) on Jul 9.
  2. BioScrip Grows with CarePoint Buyout - Analyst Blog

    June 18, 2013
    BioScrip to takeover CarePoint Partners for $223 million.
  3. Still Neutral on Walgreens - Analyst Blog

    January 21, 2013
    We reiterate our Neutral recommendation on Walgreens (WAG) following the first quarter fiscal 2013 results. While the company's ...
  4. CenturyTel and More Big Movers in Services on November 8, 2012

    November 8, 2012
    The morning has been bad for the market. The Nasdaq has slipped 0.5%; the S&P 500 has declined 0.2%; and the Dow has fallen ...
  5. Walgreen Eyes Another Acquisition - Analyst Blog

    July 6, 2012
    Acquisition spree continues for the leading retail pharmacy chain, Walgreen (WAG) as it recently entered into an agreement ...
  6. BioScrip Maintained at Neutral - Analyst Blog

    June 14, 2012
    We are maintaining our Neutral recommendation on BioScrip Inc. (BIOS) with a target price of $7.25. BioScrip reported a ...
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center